Skip to main content

Animations

MJFF Publications

7681 - 7690 of 8808 Results
Title
Year
  • Year
  • 2025
  • 2020
  • 2025
  • 2022
  • 2018
  • 2024
  • 2018
  • 2024
  • 2025
  • 2024
  • Summary Details
    RESTRICTED
    Title: The pyrethroid insecticide deltamethrin disrupts neuropeptide and monoamine signaling pathways in the gastrointestinal tract
    Journal Name: Toxicological Sciences
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/toxsci/kfaf076
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Safety and immunogenicity of the α-synuclein active immunotherapeutic PD01A in patients with Parkinson's disease: a randomised, single-blinded, phase 1 trial
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30136-8
    Citation Count: 121
  • Summary Details
    OPEN
    Title: Topological influence of immediate-early genes in brain genetic networks and their link to Alzheimer's disease
    Journal Name: Computers in Biology and Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.compbiomed.2025.110043
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Mitoguardin-2–mediated lipid transfer preserves mitochondrial morphology and lipid droplet formation
    Journal Name: Journal of Cell Biology
    Publisher: Rockefeller University Press
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1083/jcb.202207022
    Citation Count: 36
  • Summary Details
    OPEN
    Title: The vermiform appendix impacts the risk of developing Parkinson’s disease
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.aar5280
    Citation Count: 249
  • Summary Details
    OPEN
    Title: In-depth mass-spectrometry reveals phospho-RAB12 as a blood biomarker of G2019S LRRK2-driven Parkinson’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awae404
    Citation Count: 0
  • Summary Details
    OPEN
    Title: The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson’s disease
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-018-34490-9
    Citation Count: 143
  • Summary Details
    OPEN
    Title: Structural and Functional Characterization of the Most Frequent Pathogenic PRKN Substitution p.R275W
    Journal Name: Cells
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/cells13181540
    Citation Count: 2
  • Summary Details
    OPEN
    Title: The Liquid State of RIM1α and RBP Condensates is Maintained by Lipids
    Journal Name: ACS Nano
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acsnano.5c07661
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Genetic and clinical study of PARK7 in Japanese Parkinson's disease
    Journal Name: Heliyon
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.heliyon.2024.e35271
    Citation Count: 2
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.